Dexco S.A.

BOVESPA:DXCO3 Stok Raporu

Piyasa değeri: R$4.4b

Dexco Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Raul Guaragna

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliğin/a
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi7.8yrs

Son yönetim güncellemeleri

Recent updates

Analiz Makalesi May 18

Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture

Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...
Anlatı Güncellemesi May 02

DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook

Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.
Anlatı Güncellemesi Apr 18

DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside

Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.
Anlatı Güncellemesi Apr 04

DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook

Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Anlatı Güncellemesi Mar 21

DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside

Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.
Anlatı Güncellemesi Mar 06

DXCO3: Planned Stock Split Will Support Positive Long Term Outlook

Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).
Anlatı Güncellemesi Feb 20

DXCO3: Future Stock Split Will Support A More Attractive Share Repricing

Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).
Anlatı Güncellemesi Feb 06

DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside

Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.
Anlatı Güncellemesi Jan 23

DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook

Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).
Analiz Makalesi Jan 23

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Anlatı Güncellemesi Jan 08

DXCO3: Future Margins And Stock Split Plan Will Support Upside

Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.
Analiz Makalesi Dec 25

Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar

With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...
Anlatı Güncellemesi Dec 23

DXCO3: Stronger Future Margins And Investor Day May Drive Upside

Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.
Analiz Makalesi Nov 13

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...
Analiz Makalesi Oct 06

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Anlatı Güncellemesi Sep 06

Urbanization Trends And Digital Platforms Will Expand Market Reach

With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.
Analiz Makalesi Mar 21

Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...
Analiz Makalesi Mar 15

Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
User avatar
Yeni Anlatı Mar 10

New Ceramic Tiles Factory In Botucatu Will Improve Future Operations

Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.
Analiz Makalesi Feb 12

Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analiz Makalesi Dec 20

Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...
Analiz Makalesi Dec 02

There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...
Analiz Makalesi Oct 26

Is Dexco (BVMF:DXCO3) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analiz Makalesi Aug 10

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...
Analiz Makalesi Aug 08

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...
Analiz Makalesi Jul 19

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
Analiz Makalesi May 13

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...
Analiz Makalesi May 04

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...
Analiz Makalesi Apr 15

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analiz Makalesi Mar 14

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...
Analiz Makalesi Jan 19

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...
Analiz Makalesi Jan 04

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analiz Makalesi Dec 04

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...
Analiz Makalesi Oct 08

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analiz Makalesi Sep 13

Is Dexco (BVMF:DXCO3) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

CEO

Raul Guaragna

no data
Görev süresi

Mr. Raul Guimaraes Guaragna is President & Chairman of the Board of Dexco S.A. Mr. Guaragna was VP, Director of Deca & Coatings Division and Member of Executive Board of Dexco S.A. Mr. Guaragna was Head of...


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Alfredo Setubal
Chairman9.2yrsVeri yok0.038%
R$ 1.7m
Alfredo Arruda Villela Filho
Vice Chairman30.3yrsVeri yok0.74%
R$ 32.6m
Rodolfo Villela Marino
Alternate Memberno dataVeri yok0.71%
R$ 31.2m
Ricardo Setubal
Director18.1yrsVeri yok0.074%
R$ 3.3m
Helio Seibel
Vice Chairman9.2yrsVeri yokVeri yok
Andrea Seibel
Director5.3yrsVeri yok1.18%
R$ 52.0m
Paula Setubal
Substitute Member6yrsVeri yokVeri yok
Marcio Torres
Independent Director6.3yrsVeri yokVeri yok
Alex Seibel
Substitute Member5.3yrsVeri yokVeri yok
Andréa de Lima Rolim
Independent Directorno dataVeri yokVeri yok
Harry Junior
Directorno dataVeri yokVeri yok
Marcos Bicudo
Independent Directorno dataVeri yokVeri yok
7.8yrs
Ortalama Görev Süresi
59.5yo
Ortalama Yaş

Deneyimli Yönetim Kurulu: DXCO3 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.8 yıldır).


Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/23 04:30
Gün Sonu Hisse Fiyatı2026/05/22 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Dexco S.A. 15 Bu analistlerden 10, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Guilherme RositoBofA Global Research
Rafael BarcellosBradesco S.A. Corretora de Títulos e Valores Mobiliários
Carlos Palhares SequeiraBTG Pactual